Business Wire

GSMA

27.2.2020 09:32:12 CET | Business Wire | Press release

Share
GSMA: ICT Industry Agrees Landmark Science-based Pathway to Reach Net Zero Emissions

The ICT industry is today taking an unprecedented step forward in tackling climate change with the release of the first-ever science-based pathway to reduce Greenhouse Gas (GHG) emissions across the telecoms sector. This supports the GSMA’s commitment to helping the mobile industry achieve Net Zero carbon emissions by 2050.

The new Science-Based Target (SBT) is the result of a collaboration between the ITU, GeSI, the GSMA, and SBTi to develop a sector-specific decarbonisation pathway that allows ICT companies to set targets in line with the latest climate science. It includes emissions reductions trajectories for mobile, fixed and data centre operators to meet the ambitious Paris Agreement goal of limiting global warming to 1.5°c, designed to substantially reduce the risks and effects of climate change.

Twenty nine operator groups representing 30 per cent of global mobile connections are already committed to SBTs. These include America Movil, AT&T, BT, Bharti Airtel, Deutsche Telekom, Elisa, Far Eastone, KPN, Magyar Telekom, NTT DOCOMO, Orange, Proximus, Reliance Jio Infocomm, Safaricom, Singtel, SK Telecom, STC, Swisscom, T Mobile USA, Taiwan Mobile, TDC, Tele2, Telefónica, Telekom Austria, Telenor, Telia, Telstra, Verizon, and Vodafone.

Many more will now be able to set targets by applying the trajectory recommendations released today.

“Today’s landmark agreement underlines how the ICT sector is taking urgent and unprecedented action in response to the climate emergency,” said Mats Granryd, Director General, GSMA. “The mobile industry is one of the first major sectors in the world to voluntarily set an SBT for emissions reductions. Our sector will form the backbone to the future global economy and has a unique role to play in reaching a Net Zero economy. A decarbonised world will be a digital world, so we must show leadership and take responsibility for driving positive climate action.”

The GSMA is also launching a Climate Toolkit for operators today which includes company guidance for setting science-based targets. Further information is available at: https://www.gsma.com/betterfuture/climate-action-toolkit

Renewable energy to drive emissions reductions

The SBT sets emissions trajectory reductions over the decade (2020-2030) for each ICT sub- sector. For example, mobile network operators adopting the SBT are required to reduce emissions by at least 45 per cent over this period. Companies are required to set one target for their combined Scope 1 and 2 emissions, with additional guidance provided for managing Scope 3 emissions1 .

The switch to renewable and low-carbon electricity is expected to account for the bulk of reductions over this period, alongside efforts by operators to become more energy efficient. Access to renewable energy, which can vary widely depending on an operator’s geographic location is, therefore, a key factor determining an operator’s ability to meet the SBT.

The ICT sector pathway SBT was approved by the Science-Based Target Initiative (SBTi) this month following a consultation period. Full details are provided in the official ITU standard: GHG emissions trajectories for the ICT sector compatible with the UNFCCC Paris Agreement (Ref: Recommendation ITU L.1470).

Mobile industry demonstrating leadership on climate action

Today’s announcement forms part of the GSMA’s climate action roadmap for the mobile industry, which has already seen operators disclose their climate impacts, energy, and emissions via the internationally recognised CDP global disclosure system.2

The GSMA is working with participating operators and partnering with the international community, climate experts and third-party organisations to advance industry progress, establish best practices, and support disclosure and target setting. The work forms part of the industry’s journey to support the delivery of the UN’s Sustainable Development Goals (SDGs), specifically SDG #13 on Climate Action.

The industry is also committed to advancing mobile technology innovations in areas such as big data and IoT that can enable energy efficient and environmental solutions across multiple sectors, including transport, manufacturing, agriculture, building, and energy. A recent report produced by the GSMA and the Carbon Trust calculated that the use of mobile technology enabled a global reduction in emissions of around 2,135 million tonnes CO2 e in 20183 . These emissions savings were almost ten times greater than the global carbon footprint of the mobile industry itself.

-ENDS-

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA

1 https://www.epa.gov/greeningepa/greenhouse-gases-epa

2 https://www.gsma.com/newsroom/press-release/worlds-leading-mobile-operators-to-disclose-climate-impacts-as-part-of-new-gsma-led-climate-action-roadmap/

3 https://www.gsma.com/newsroom/press-release/mobile-technologies-enabling-huge-carbon-reductions-in-response-to-climate-emergency/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release

Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release

Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release

− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex

Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 202615.10.2026 02:10:00 CEST | Press release

Celltrion to showcase its broad IBD portfolio, including Remsima™ IV, Remsima™ SC, the newly launched Remsima™ IV Liquid formulation, Steqeyma™ and Yuflyma™Symposium and Meet the Experts sessions to highlight long-term clinical evidence and real-world experience with subcutaneous (SC) infliximab (Remsima™ SC) across different IBD patient scenarios Celltrion, Inc. (KRX:068270) announced its participation in United European Gastroenterology (UEG) Week 2026, in Barcelona, Spain (Oct. 17-20), highlighting its inflammatory bowel disease (IBD) treatment portfolio, led by Remsima™ SC (subcutaneous infliximab). Celltrion will showcase its comprehensive infliximab portfolio, comprising Remsima™ intravenous (IV) and subcutaneous (SC) formulations, as well as the Remsima™ IV liquid formulation launched in Europe earlier this year.1 Additionally, the company will highlight its broader IBD portfolio, including SteQeyma™ (ustekinumab) and Yuflyma™ (adalimumab), reflecting its continued efforts to ex

ProcureTEX Returns for Its Second Year, Bringing AI and Best-of-Breed Procurement Technology to Amsterdam14.10.2026 18:26:00 CEST | Press release

Founding partners Beroe, Keelvar and Zip bring back the community-driven event with a practitioner-shaped agenda spanning real-world AI use and the future of procurement ProcureTEX, the community-driven event for best-of-breed procurement technology, returns for its second year on November 3, 2026, at Circa in Amsterdam. Following its London debut in 2025, the event sharpens its focus on how AI is reshaping procurement. It will bring together over 250 procurement leaders and digital transformation teams from large enterprises, with vetted best-of-breed technology providers, to see AI agents and interoperable tools working together on real enterprise challenges. Co-founded by Beroe, Keelvar and Zip, the event is built on the belief that the future of procurement isn’t a monolithic all-in-one suite, but an ecosystem of best-of-breed tools working together. It is designed for procurement and enterprise leaders seeking scalable, modern solutions, whether they’re driving transformation, fru

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye